Center of Excellence: Migraine: Journal Articles

• Migraine Diagnosis, Treatment by Women's Healthcare Providers Migraine is nearly three times more prevalent in women than men, but this study suggests that many women's healthcare providers have knowledge gaps regarding migraine management in their patients.
  Headache, February 22, 2021
• GABA and Glutamate in Pediatric Migraine Using magnetic resonance spectroscopy, this study investigated the role of GABA and glutamate disturbances in children with migraine, and how the effects might differ from those in adult migraneurs.
  Pain, January 19, 2021
• Eptinezumab Efficacy in Sustained Prevention of Migraine This study demonstrates that the migraine preventive effect of eptinezumab is rapid and sustained, with onset of optimal preventive efficacy observed on the day following the initial dose.
  Headache, January 07, 2021
• Smartphone-Delivered Progressive Muscle Relaxation for Migraine Might a smartphone application, RELAXaHEAD, which delivers a progressive muscle relaxation intervention, be effective for migraine prevention as well as acceptable to users?
  Headache, December 31, 2020
• Assessing the Validity of the 24-Hr Migraine QoL Questionnaire The 24-Hour Migraine Quality of Life Questionnaire has been in use since the 1990's. This study aimed to provide evidence for its content validity as well as its usability in electronic form.
  Headache, December 01, 2020
• Real-World Experience With Erenumab for Migraine Prevention This post-market analysis investigated the real-world performance of erenumab, a CGRP receptor monoclonal antibody, in a cohort of migraine patients after six months of therapy.
  Headache, November 17, 2020
• Efficacy and Placebo Effects of CGRP Antibodies for Migraine This study showed that while calcitonin gene-related peptide antibodies are effective in treating migraine, a high percentage of the benefit is from contextual effects, including placebo effect.
  Headache, October 16, 2020
• Lifestyle Advice for Pediatric Migraine Which lifestyle interventions have a proven therapeutic effect on migraine frequency in children? This article provides practical advice for counseling children and teenagers with migraine.
  Seminars in Neurology, September 25, 2020
• Fremanezumab Monthly, Quarterly Doses and Efficacy Responses This paper describes the development of exposure-response models for monthly and quarterly dosing of fremanezumab, a monoclonal antibody for preventive treatment of episodic and chronic migraine.
  Headache, September 18, 2020
• Diet and Nutrition in Migraine Triggers and Treatment How do dietary patterns and diet-related triggers impact the development of migraine? Can diet interventions improve outcomes such as frequency or duration of migraine?
  Headache, September 11, 2020
• Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine OnabotulinumtoxinA is a staple of chronic migraine prevention that significantly reduces headache frequency. This review elucidates its pharmacodynamics as they relate to the sensory realm.
  Headache, September 04, 2020
• Migraine and Ischemic Stroke in Women. A Narrative Review Review the epidemiological and mechanistic evidence of the migraine-stroke relationship and its risk factors in women, with a focus on those who experience migraine with aura.
  Headache, August 18, 2020
• Migraine Care in the Era of COVID-19 This article outlines helpful strategies for providing remote care to migraine patients during the COVID-19 pandemic, while also urging health insurers to remove barriers to migraine care.
  Headache, August 04, 2020
• Preference for Lighting Chromaticity in Migraine With Aura How do individuals who experience migraine with aura differ from healthy controls in their preferences for the color of light, or chromaticities, considered comfortable for reading?
  Headache, June 30, 2020
• Behavioral Therapy Preferences in People With Migraine Behavioral therapies for migraine prevention tend to be underutilized. What are the preferences of migraineurs in terms of behavioral therapies, and how likely are they to pursue these options?
  Headache, June 23, 2020
• Anti-CGRP mABs and Botulinum Toxin for Migraine Prevention This article presents a pathophysiological rationale for dual therapy with anti-CGRP humanized antibodies and botulinum toxin type A in the prevention of migraine.
  Headache, June 16, 2020
• Predictors of Response to OnabotulinumtoxinA What clinical factors might predict response to onabotulinumtoxinA therapy for migraine?
  Headache, May 18, 2020
• Plasma Glucose Levels During Spontaneous Migraine Attacks How do blood glucose levels change during spontaneous migraine attacks? Is there a correlation between changes in blood glucose and perceived pain intensity or aura symptoms?
  Headache, May 04, 2020
• Vestibular Migraine: Treatment and Prognosis Review the prophylaxis and management of vestibular migraine in this overview.
  Seminars in Neurology, April 27, 2020
• Neuroimaging for Migraine: The AHS Evidence-Based Guideline This systemic review examined the evidence regarding the diagnostic utility of neuroimaging in adult patients seeking outpatient treatment for migraine.
  Headache, April 14, 2020